APONTIS PHARMA confirms 2022 forecast after successful nine-month period – Strong Single Pill pipeline to achieve medium-term targets
EQS-News: APONTIS PHARMA AG / Key word: 9 Month figures/Quarterly / Interim Statement APONTIS PHARMA confirms 2022 forecast after successful nine-month period – Strong Single Pill... | November 10, 2022
Source: marketscreener.com